Wh. Chou et al., COMPARISON OF HEPATITIS-C VIRUS-STRAINS OBTAINED FROM HEMODIALYSIS-PATIENTS, Japanese Journal of Medical Science & Biology, 46(4), 1993, pp. 191-202
To understand what genotypes of hepatitis C virus (HCV) exist in Taiwa
n, we chose the non-structure 5 (NS5) region of the HCV genome for the
target area of reverse transcription-polymerase chain reaction (RT-PC
R) to detect HCV RNA from sera of hemodialysis patients. Of 39 serum s
amples which were positive for the HCV antibody among 87 samples from
hemodialysis patients, 12 (antibody against HCV core protein, OD > 2)
were examined by the RT-PCR. The plasmid pUC19 was used to clone HCV c
DNAs in the NS5 region (401 bp) derived from 11 serum samples which we
re positive for HCV RNA. Sequence analyses of individual clone of thes
e 11 amplified cDNA fragments were performed. Dr. Cha's classification
(16) suggested that two genotypes of HCV were found in these serum sa
mples; type II(2/18.2%) and type III (9/81.8%). Our study indicates al
so that NS5 is an adequate target region to differentiate HCV strains
derived from different patients in the same hospital. The analysis of
the amplified cDNA in the NS5 region of the HCV genome will therefore
provide suitable information to perform a molecular epidemiological st
udy on the transmission routes of this important virus infection.